New indication for AclastaNovartis' Aclasta (zoledronic acid injection) is now approved for use as a once-yearly intravenous (IV) infusion in the prevention and treatment of corticosteroid-induced osteoporosis, to increase bone mineral density. CFP announces new presidentPeter Marshall has been appointed president of the Canadian Foundation for Pharmacy for 2009. The case for MD pensions Is it fair that Canadian doctors' retirement incomes ‘suffer the vagaries of the market’? Two new hospitals proposed for Vancouver Island PENSIONS: The European experience mapped PENSIONS: My German pension Clinical in Brief: Incidental findings common in cervical spine CTs PENSIONS: Canadian pension rules outdated Faculties of medicine creating clearer rules for pharma funding BAD ADVICE: Psychiatrists, don't shrink from sudoku First Previous 2301 2302 2303 2304 2305 Next Last
